|
08.12.2010
CA: Health Canada updates Q&A for the preparation of eCTD submissions
|
 |
|
Health Canada has released an updated version of their "Questions and Answers for the Guidance for Industry: Preparation of Drug Submissions in the Electronic Common Technical Document (eCTD) Format". As usual the updated Q&A are available directly on the Health Canada website and as downloadable PDF-file.
Revisions have been introduced in the updated Q&A for 14 Questions, whereas 2 Questions (Q#5 and Q#20) concerning previous submission formats were completely withdrawn. These changes are in principle reflecting the further progress of the eCTD implementation at Health Canada as the previous "co-submission" filing format is no longer accepted since January 1st, 2010 and some submission types are even accepted electronic-only since August, 2010.
New Questions #26 - 36 were introduced giving further guidance on the eCTD requirements. The more prominent changes include: - Q26: External hyperlinks to certain websites (e.g. sponsor`s own website) or to e-Mail addresses are now accepted. Note: Any external links to information pertinent to the review process will still result in a validation failure
- Q30: Health Canada now accepts PDF 1.7 files
- Q31: Non-eCTD hybrid filing format is requested in case a valid eCTD cannot be provided by an applicant
- Q33: The MD5-checksum file (index-md-5.txt) is no longer required in printed version as annex to the cover letter
- Q35: Clarification on how to present information about submission fees is provided
- Q36: Clarification on how to provided Drug Master Files in eCTD format is provided
For detailed information, please see the updated Q&A.
[Source: Health Canada website]
- Related News:
CA: Update from Health Canada regarding scope of submissions being accepted in eCTD format and acceptance of electronic-only submissions - 24.08.2010 12:01
<- Back to: News
|
|